Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cyclin B2 pseudogene 1 (CCNB2P1) is a **processed pseudogene** that shares sequence similarity with the coding gene for cyclin B2 (CCNB2), a member of the cyclin family involved in cell cycle regulation. The CCNB2P1 gene does not produce a functional protein due to multiple frameshifts and its non-coding status. Such pseudogenes are catalogued in genomic research but do not serve as functional molecular targets, though some pseudogenes can play regulatory roles as non-coding RNAs. There is no evidence that CCNB2P1 functions as a therapeutic target, nor are there described drug interactions, mechanisms of action, or biomarker roles for this pseudogene[4][7][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cyclin B2 pseudogene 1 (CCNB2P1).